PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma. | Eur J Cancer;40(4): 614-8, 2004 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.

Takano, T; Miyauchi, A; Matsuzuka, F; Yoshida, H; Nakata, Y; Kuma, K; Amino, N.

Affiliation

Takano T; Department of Laboratory Medicine, Osaka University Graduate School of Medicine, D2, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. ttakano@labo.med.osaka-u.ac.jp

Eur J Cancer ; 40(4): 614-8, 2004 Mar.

Article in En | MEDLINE | ID: mdl-14962731

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / RNA, Neoplasm / Thyroid Neoplasms / Proteins / Biomarkers, Tumor Type of study: Diagnostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2004 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / RNA, Neoplasm / Thyroid Neoplasms / Proteins / Biomarkers, Tumor Type of study: Diagnostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2004 Document type: Article Affiliation country: Country of publication: